Dose-effect relationship of norepinephrine in the treatment of hypotension after cesarean section in severe preeclampsia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041044

Enrollment

Unknown

Registered

2020-12-16

Start date

2020-12-10

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension after anesthesia

Interventions

Noradrenaline Group:The dose of noradrenaline was adjusted up and down according to the effective of treat hypotension

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of severe preeclampsia; (2) ASA II-III; (3) Aged 20-35 years; (4) BMI 36 weeks; (6) Hb >= 90g/L-1.

Exclusion criteria

Exclusion criteria: (1) Liver and kidney function is obviously abnormal before operation; (2) Hypertension complicated with pregnancy; (3) Complicated with diabetes or other metabolic diseases; (4) Respiratory failure or heart failure before operation; (5) Anesthesia level is lower than T10 or higher than T6.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Secondary

Measure	Time frame
hypertension;hypotension;bradycardia;	—

Countries

China

Contacts

Public ContactWenkai Wang

Department of Anesthesiology, The Sixth People's Hospital of Huizhou

mywenkai@163.com+86 1923612371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026